These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 35953355)

  • 21. Relationship of Familial Hypercholesterolemia and High Low-Density Lipoprotein Cholesterol to Ischemic Stroke: Copenhagen General Population Study.
    Beheshti S; Madsen CM; Varbo A; Benn M; Nordestgaard BG
    Circulation; 2018 Aug; 138(6):578-589. PubMed ID: 29593013
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A Belgian consensus strategy to identify familial hypercholesterolaemia in the coronary care unit and its subsequent cascade screening and treatment: BEL-FaHST (The BELgium Familial Hypercholesterolaemia STrategy).
    Descamps OS; Van Caenegem O; Hermans MP; Balligand JL; Beauloye C; Bondue A; Carlier S; Castermans E; Chenot F; Claeys M; De Block C; de Leener A; De Meester A; Demeure F; De Raedt H; Desmet W; Elegeert I; Guillaume M; Hoffer E; Kacenelenbogen R; Lancellotti P; Langlois M; Leone A; Mertens A; Paquot N; Vanakker O; Vanoverschelde JL; Verhaegen A; Vermeersch P; Wallemacq C; Rietzschel E;
    Atherosclerosis; 2018 Oct; 277():369-376. PubMed ID: 30270073
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Statins do not increase the risk of developing type 2 diabetes in familial hypercholesterolemia: The SAFEHEART study.
    Fuentes F; Alcala-Diaz JF; Watts GF; Alonso R; Muñiz O; Díaz-Díaz JL; Mata N; Sanchez Muñoz-Torrero JF; Brea Á; Galiana J; Figueras R; Aguado R; Piedecausa M; Cepeda JM; Vidal JI; Rodríguez-Cantalejo F; López-Miranda J; Mata P;
    Int J Cardiol; 2015 Dec; 201():79-84. PubMed ID: 26296047
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Long-term outcomes after acute myocardial infarction in patients with familial hypercholesterolemia: The French registry of Acute ST-elevation and non-ST-elevation Myocardial Infarction program.
    Danchin N; Farnier M; Zeller M; Puymirat E; Cottin Y; Belle L; Lemesle G; Cayla G; Ohlmann P; Jacquemin L; Perret T; Angoulvant D; Albert F; Ferrières J; Schiele F; Simon T;
    J Clin Lipidol; 2020; 14(3):352-360.e6. PubMed ID: 32527469
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prevalence of familial hypercholesterolemia phenotype and ten-year risk of cardiovascular events in a working population in primary prevention: The ICARIA study.
    Sánchez-Ramos A; Fernández-Labandera C; Vallejo-Vaz AJ; Bonacho EC; Quevedo-Aguado L; Catalina-Romero C; Valdivielso P; Sánchez-Chaparro MÁ
    Atherosclerosis; 2021 Dec; 338():39-45. PubMed ID: 34785430
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Heterozygous familial hypercholesterolaemia in specialist centres in South Africa, Australia and Brazil: Importance of early detection and lifestyle advice.
    Pang J; David Marais A; Blom DJ; Brice BC; Silva PR; Jannes CE; Pereira AC; Hooper AJ; Ray KK; Santos RD; Watts GF
    Atherosclerosis; 2018 Oct; 277():470-476. PubMed ID: 30270087
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prevalence of familial hypercholesterolaemia in patients presenting with premature acute coronary syndrome.
    Hauguel-Moreau M; Aïdan V; Hergault H; Beauchet A; Pépin M; Prati G; Pillière R; Ouadahi M; Josseran L; Rodon C; Rabès JP; Charron P; Dubourg O; Massy Z; Mansencal N
    Arch Cardiovasc Dis; 2022 Feb; 115(2):87-95. PubMed ID: 35123917
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Lipoprotein(a), LDL-cholesterol, and hypertension: predictors of the need for aortic valve replacement in familial hypercholesterolaemia.
    Pérez de Isla L; Watts GF; Alonso R; Díaz-Díaz JL; Muñiz-Grijalvo O; Zambón D; Fuentes F; de Andrés R; Padró T; López-Miranda J; Mata P
    Eur Heart J; 2021 Jun; 42(22):2201-2211. PubMed ID: 33437997
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pooling and expanding registries of familial hypercholesterolaemia to assess gaps in care and improve disease management and outcomes: Rationale and design of the global EAS Familial Hypercholesterolaemia Studies Collaboration.
    ; Vallejo-Vaz AJ; Akram A; Kondapally Seshasai SR; Cole D; Watts GF; Hovingh GK; Kastelein JJ; Mata P; Raal FJ; Santos RD; Soran H; Freiberger T; Abifadel M; Aguilar-Salinas CA; Alnouri F; Alonso R; Al-Rasadi K; Banach M; Bogsrud MP; Bourbon M; Bruckert E; Car J; Ceska R; Corral P; Descamps O; Dieplinger H; Do CT; Durst R; Ezhov MV; Fras Z; Gaita D; Gaspar IM; Genest J; Harada-Shiba M; Jiang L; Kayikcioglu M; Lam CS; Latkovskis G; Laufs U; Liberopoulos E; Lin J; Lin N; Maher V; Majano N; Marais AD; März W; Mirrakhimov E; Miserez AR; Mitchenko O; Nawawi H; Nilsson L; Nordestgaard BG; Paragh G; Petrulioniene Z; Pojskic B; Reiner Ž; Sahebkar A; Santos LE; Schunkert H; Shehab A; Slimane MN; Stoll M; Su TC; Susekov A; Tilney M; Tomlinson B; Tselepis AD; Vohnout B; Widén E; Yamashita S; Catapano AL; Ray KK
    Atheroscler Suppl; 2016 Dec; 22():1-32. PubMed ID: 27939304
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Liquid Biopsy of Extracellular Microvesicles Maps Coronary Calcification and Atherosclerotic Plaque in Asymptomatic Patients With Familial Hypercholesterolemia.
    Chiva-Blanch G; Padró T; Alonso R; Crespo J; Perez de Isla L; Mata P; Badimon L
    Arterioscler Thromb Vasc Biol; 2019 May; 39(5):945-955. PubMed ID: 30866660
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mutational analysis and genotype-phenotype relation in familial hypercholesterolemia: The SAFEHEART registry.
    Bourbon M; Alves AC; Alonso R; Mata N; Aguiar P; Padró T; Mata P
    Atherosclerosis; 2017 Jul; 262():8-13. PubMed ID: 28475941
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Lipid Screening in Childhood and Adolescence for Detection of Familial Hypercholesterolemia: Evidence Report and Systematic Review for the US Preventive Services Task Force.
    Lozano P; Henrikson NB; Dunn J; Morrison CC; Nguyen M; Blasi PR; Anderson ML; Whitlock EP
    JAMA; 2016 Aug; 316(6):645-55. PubMed ID: 27532919
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Non-coronary atherosclerotic cardiovascular disease in patients with familial hypercholesterolaemia.
    Anagnostis P; Vaitsi K; Mintziori G; Goulis DG; Mikhailidis DP
    Curr Med Res Opin; 2020 May; 36(5):731-740. PubMed ID: 32096673
    [No Abstract]   [Full Text] [Related]  

  • 34. Effect of competing mortality risks on predictive performance of the QRISK3 cardiovascular risk prediction tool in older people and those with comorbidity: external validation population cohort study.
    Livingstone S; Morales DR; Donnan PT; Payne K; Thompson AJ; Youn JH; Guthrie B
    Lancet Healthy Longev; 2021 Jun; 2(6):e352-e361. PubMed ID: 34100008
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Knowledge, awareness and practice regarding familial hypercholesterolaemia among primary care physicians in Malaysia: The importance of professional training.
    Azraii AB; Ramli AS; Ismail Z; Abdul-Razak S; Mohd-Kasim NA; Ali N; Watts GF; Nawawi H
    Atherosclerosis; 2018 Oct; 277():508-516. PubMed ID: 30270092
    [TBL] [Abstract][Full Text] [Related]  

  • 36. WHO cardiovascular disease risk prediction model performance in 10 regions, China.
    Yang S; Ding Y; Yu C; Guo Y; Pang Y; Sun D; Pei P; Yang L; Chen Y; Du H; Schmidt D; Stevens R; Bennett D; Clarke R; Chen J; Chen Z; Li L; Lv J;
    Bull World Health Organ; 2023 Apr; 101(4):238-247. PubMed ID: 37008262
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Exploration into lipid management and persistent risk in patients hospitalised for acute coronary syndrome in Japan (EXPLORE-J): protocol for a prospective observational study.
    Nakamura M; Uno K; Hirayama A; Ako J; Nohara A; Arai H; Harada-Shiba M
    BMJ Open; 2017 Jul; 7(6):e014427. PubMed ID: 28674132
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical experience of scoring criteria for Familial Hypercholesterolaemia (FH) genetic testing in Wales.
    Haralambos K; Whatley SD; Edwards R; Gingell R; Townsend D; Ashfield-Watt P; Lansberg P; Datta DB; McDowell IF
    Atherosclerosis; 2015 May; 240(1):190-6. PubMed ID: 25797312
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prevalence Of familial hypercholeSTerolaemia (FH) in Italian Patients with coronary artERy disease: The POSTER study.
    Gulizia MM; Maggioni AP; Abrignani MG; Bilato C; Mangiacapra F; Sanchez FA; Piovaccari G; Montagna L; Marini M; De Biasio M; Averna M; Casula M; Colivicchi F; Fabbri G; Lucci D; Zampoleri V; Catapano AL;
    Atherosclerosis; 2020 Sep; 308():32-38. PubMed ID: 32823190
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effectiveness of alternative strategies to define index case phenotypes to aid genetic diagnosis of familial hypercholesterolaemia.
    Clarke RE; Padayachee ST; Preston R; McMahon Z; Gordon M; Graham C; Crook MA; Wierzbicki AS
    Heart; 2013 Feb; 99(3):175-80. PubMed ID: 23213176
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.